Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000169 |
Acrodermatitis |
|
Zinc |
6.03 | 17190629 16889938 17202136 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.82 | 17119284 16325427 16580781 16410023 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
5.41 | 16916123 |
MESH:D001249 |
Asthma |
|
Zinc |
3.04 | 17085522 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18621663 |
MESH:D001321 |
Autistic Disorder |
|
Methionine |
3.59 | 16917939 19056591 19267885 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
5.25 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.53 | 18320071 19208741 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.79 | 16705839 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
5.30 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
5.30 | 16543248 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.92 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.03 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
marker/mechanism |
|
| 18252227 17173049 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Methionine |
4.43 | 19267885 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.38 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.11 | 18981723 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.44 | 19302082 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.58 | 18551238 |
MESH:D002658 |
Developmental Disabilities |
marker/mechanism |
|
| 16284256 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.57 | 16479319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
2.05 | 18551238 21346803 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.84 | 19294695 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
2.93 | 16543248 |
MESH:D005756 |
Gastritis |
|
Zinc |
5.52 | 17241300 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
4.19 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.74 | 19215824 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.83 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
6.49 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
5.00 | 17241300 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
5.25 | 17276780 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.45 | 17581917 |
MESH:D007511 |
Ischemia |
|
Zinc |
5.19 | 16584753 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
3.52 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.85 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.32 | 16705839 |
MESH:D007805 |
Language Development Disorders |
marker/mechanism |
|
| 17173049 16284256 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.24 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.43 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.43 | 18460780 19387464 17679729 18704418 19010910 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.19 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Methionine |
3.50 | 15158331 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.27 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.77 | 6135515 2876786 2876784 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.69 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
3.53 | 12773700 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 16284256 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.62 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.58 | 18608210 16882708 19157545 19010910 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.49 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.87 | 19470736 17925555 19116145 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.83 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.74 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.87 | 19294695 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.48 | 17114810 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.29 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.76 | 12429649 16606632 16517595 16700911 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.42 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.87 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Methionine |
3.71 | 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.79 | 18551238 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:C536801 |
Telomeric 22q13 monosomy syndrome |
marker/mechanism |
|
| 16284256 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.63 | 17967635 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.79 | 16543248 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.59 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.59 | 19087683 17616700 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.95 | 10091137 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.64 | 17785578 |